News

Cancer is the leading cause of death in San Francisco and costs patients, families and taxpayers hundreds of millions of dollars each year. Seeing an opportunity to change this, a group that includes UC San Francisco (UCSF), the City and County of San Francisco, the San Francisco Department of

Next-generation sequencing for patients at UCSF Medical Center is prompting changes in brain tumor diagnoses for some children and a retooling of treatment plans in many cases. Sequencing is also providing valuable insights to some parents about their own susceptibility to other seemingly unrelated

“Together, we can offer patients care across a continuum of services and help them navigate their individual medical needs,” said Alan Ashworth, PhD, president of the UCSF Helen Diller Family Comprehensive Cancer Center. “They will have access to specialists in both health systems, an extensive

A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer, an aggressive disease subtype that has the poorest outcomes and accounts for as many as one in five cases. The findings are particularly noteworthy because drugs that act on

UC San Francisco is helping to launch a landmark effort by the National Institutes of Health to engage 1 million or more U.S. participants in research aimed at preventing and treating disease based on individual differences in lifestyle, environment and genetics. Four University of California

The following content originally appeared on universityofcalifornia.edu. View the original post. Scientists across the University of California system are taking aim at breast cancer. Along with developing better detection methods, researchers are making advances in imaging techniques and tapping

There’s good news on the breast cancer front: Advances in medicine are helping more women than ever survive a breast cancer diagnosis. Death rates for the disease have been declining for nearly 30 years thanks to better screening and advances in treatment. The survival rate for women diagnosed with